Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial

Autor: Song, Katerina Rok †, *, Chapagain, Ram Hari , Tamrakar, Dipesh, Shrestha, Rajeev, Kanodia, Piush, Chaudhary, Shipra, Wartel, T Anh, Yang, Jae Seung, Kim, Deok Ryun, Lee, Jinae, Park, Eun Lyeong, Cho, Haeun, Lee, Jiyoung, Thaisrivichai, Patchara, Vemula, Sridhar, Kim, Bo Mi, Gupta, Birendra, Saluja, Tarun, Pansuriya, Ruchir Kumar, Ganapathy, Ravi, Baik, Yeong Ok, Lee, Young Jin, Jeon, Suhi, Park, Youngran, Her, Howard L, Park, Youngshin, Lynch, Julia A
Zdroj: In The Lancet Global Health May 2024 12(5):e826-e837
Databáze: ScienceDirect